Cerebriu, a company that offers artificial intelligence (AI) solutions for streamlining radiology processes, and Siemens Healthineers, the top producer of magnetic resonance imaging (MRI) scanners worldwide, have partnered to incorporate Cerebriu's unique Smart ProtocolTM for Brain MRI-workflow automation software into Siemens Healthineers' MRI equipment.
Diazyme Laboratories and Maccura Biotechnology announced a collaboration to launch an FDA EUA-approved SARS-COV-2 RT-PCR diagnostic test. Located in Poway, California, Diazyme Laboratories Inc. is a Life Science Affiliate of General Atomics. Using its patented enzyme and immunoassay technology, Diazyme creates user-friendly diagnostic test reagents that may be used with automated chemistry analyzers and chemiluminescence equipment.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5472
Published Date: Dec 22, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Ans: The major factors driving the growth of the market are rising advancement in technology for clostridium diagnostics, the surge in the prevalence of foodborne illness, and the rising use of AI to launch drugs for clostridium.
Ans: The market size of clostridium diagnostics is anticipated to attain a CAGR of 13% over the forecast period, i.e., 2024-2036.
Ans: The major players in the market are Cerebriu, Diazyme Laboratories, Inc., BioMerieux, Beckman Coulter, Inc. and others.
Ans: The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
Ans: The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.